Inventor
GREGG F. KEANEY
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes24%
C07DHeterocyclic compounds24%
C07BGeneral methods of organic chemistry12%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
PatentTitleYear
11,993,586Crystalline forms of potassium channel modulators202411,926,619Certain pladienolide compounds and methods of use202411,767,319Crystalline forms of a selective c-kit kinase inhibitor202311,744,823Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same202311,542,264Heteroaromatic NMDA receptor modulators and uses thereof2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023Patents assigned to THIRD HARMONIC BIO INC (2)· patent assignee history
2023Patents assigned to CADENT THERAPEUTICS INC (1)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to EISAI R&D MAN CO LTD (1)· patent assignee history
2024Patents assigned to NOVARTIS AG (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| THIRD HARMONIC BIO INC | 2 | 2023 |
| CADENT THERAPEUTICS INC | 1 | 2023 |
| EISAI R&D MAN CO LTD | 1 | 2024 |
| NOVARTIS AG | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2024 |